In the first personal injury case that has gone to trial over Zantac, GSK and Boehringer Ingelheim have emerged with an important victory as a Chicago jury has rejected the claim of Angela Valadez that the heartburn drug caused her colon cancer.
Valadez, 89, who said she used the drug every day from 1995 to 2014, was seeking $640 million for her suffering. Earlier in the trial, a Cook County circuit judge denied her attempt to also collect punitive damages.
Valadez argued that GSK and Boehringer knew that Zantac’s main ingredient, ranitidine, could transform into a possible carcinogen called NMDA over time or when exposed to high temperatures and that the companies failed to warn customers.
https://www.fiercepharma.com/pharma/fir ... ey-victory
There might be a RNS issued by GSK at 0700hrs (UK) on this today?
Ian.